Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Special Populations
[키워드] 95% CI
ACE
ACE inhibitor
adjusted
Admission
African
angiotensin receptor blocker
ARB
association
black
cardiac risk factors and prevention
cohort study
collected data
confounders
COVID-19
COVID-19 disease
Cox proportional hazard
diabetes
diagnosed
disease
drug
Effect
England
enzyme
Epidemiology
ethnic group
finding
geographical region
group
higher risk
hypertension
ICU
ICU care
increased risk
inhibitor
intensive care
medication
participant
Patient
primary care
Primary outcome
prospective cohort study
raise
receiving
receptor
reduced risk
resulting
risk
risk of COVID-19
RT-PCR
severe COVID-19 disease
severity
significant interaction
significantly
significantly increased
sociodemographic factors
susceptibility
variables
with COVID-19
[DOI] 10.1136/heartjnl-2020-317393 PMC 바로가기 [Article Type] Special Populations
[DOI] 10.1136/heartjnl-2020-317393 PMC 바로가기 [Article Type] Special Populations